Psychoeducation for Chronic Disease Management in Re-entered Seniors
(SRRS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The trial aims to develop and test a new educational program called Psychoeducation for managing chronic diseases in older adults who have returned to their communities after incarceration. The first part of the trial identifies the most critical knowledge and skills these individuals need. The second part involves an 8-week group program to determine if it helps participants manage their chronic conditions better. The trial seeks participants who are at least 45 years old, have been incarcerated, and have a chronic health condition.
As an unphased trial, this study offers a unique opportunity to contribute to a program that could significantly improve chronic disease management for others in similar situations.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on education and skill-building, so it's unlikely that medication changes are required.
What prior data suggests that this psychoeducational intervention is safe?
Research has shown that psychoeducation is a safe and well-accepted method for managing long-term illnesses. Studies have found that these programs assist individuals in adjusting to life with a chronic illness. No major reports of negative effects from psychoeducation exist, indicating it is a low-risk option. Participants often find these programs beneficial, reporting improvements in quality of life and better management of health conditions.12345
Why are researchers excited about this trial?
Researchers are excited about this psychoeducational approach because it focuses on empowering seniors with chronic diseases by boosting their knowledge, skills, and motivation to manage their health. Unlike traditional treatments that often rely on medication or clinical interventions, this method leverages group support and education to enhance resilience and self-management. By meeting weekly, participants can share experiences, learn from each other, and develop practical strategies for better health outcomes, potentially leading to more sustainable and personalized disease management.
What evidence suggests that this psychoeducation is effective for chronic disease management?
Research has shown that psychoeducation, which involves teaching people about their health conditions, can help them adhere to medication plans and improve their attitude towards managing chronic illnesses. Studies have found that these programs enhance emotional and social well-being and teach skills like relaxation and positive thinking. While detailed evidence on overall health improvements is limited, these programs have successfully eased the burden on caregivers of people with chronic diseases. This trial will focus on a group-based psychoeducational intervention, aiming to empower older adults to take control of their health by educating them about their conditions. This method shows promise in helping older adults manage chronic diseases effectively.16789
Are You a Good Fit for This Trial?
This trial is for older adults, aged 45 and above, who have recently re-entered the community from jail or prison. Participants must have at least one chronic health condition and be able to speak and understand English.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete a baseline survey and participate in a focus group
Intervention
Participants engage in an 8-week psychoeducational intervention, meeting once weekly
Follow-up
Participants complete three follow-up surveys to assess the intervention's impact on chronic disease management
What Are the Treatments Tested in This Trial?
Interventions
- Psychoeducation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Louisville
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator